Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G-quadruplex-forming sequence-containing long non-coding RNA (GSEC) is a long non-coding RNA characterized by a guanine-rich sequence capable of forming stable G-quadruplex (G4) structures. GSEC is upregulated in colorectal cancer tissues and promotes cancer cell migration by binding to and inhibiting the regulatory helicase DHX36, which is responsible for unwinding G-quadruplexes in RNA. Loss of GSEC reduces cell motility, highlighting a specific role in cancer progression, particularly metastasis, via modulation of RNA secondary structure and helicase interaction. GSEC is one of a growing class of lncRNAs where G4 structural motifs act as functional regulators of protein activity and possibly gene expression[3].
Inhibits DHX36 (DEAH box polypeptide 36) RNA helicase by direct binding through its G-quadruplex structure, thereby modulating the unwinding of G-quadruplexes and affecting downstream cellular activities related to gene expression and migration[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G-quadruplex-forming sequence-containing long non-coding RNA (GSEC).